Literature DB >> 2732787

Formation of hydroxyapatite in hydrogels from tetracalcium phosphate/dicalcium phosphate mixtures.

A Sugawara, J M Antonucci, S Takagi, L C Chow, M Ohashi.   

Abstract

Apatitic calcium phosphate cements, formed by the ambient reaction of tetracalcium phosphate (TTCP) with dicalcium phosphates (DCP), have been recently reported. H2O or dilute aq. H3PO4 (0.2%) is used as the liquid vehicle for this reaction. The aim of this study was to ascertain if hydroxyapatite (HAp) can form in self-cured hydrogel composites containing TTCP/DCP mixes. The setting times (ST) and diametral tensile strengths (DTS) of these hydrogel composites were also determined. The hydrogels were of two types: (1) vinyl thermosets derived from the copolymerization of HEMA (2-hydroxyethyl methacrylate) and cross-linking monomers, and (2) polyelectrolyte-based hydrogels formed from aq. poly(alkenoic acids), e.g., poly(acrylic acid). Cylindrical specimens 6 mm D x 3 mm H were prepared and stored in H2O for up to 30 days. The HEMA composites were hardened in 7-15 min by free radical initiation (benzoyl peroxide/tertiary aromatic amine). The polyelectrolyte cements were hardened in 6-8 min. After various periods of storage in H2O at 37 degrees C, some of the specimens were examined by X-ray spectroscopy for HAp. HAp formation was not observed in the HEMA composites even after 30 days of H2O storage but was detected in the polyacid cements. The 24-h DTS values of the HEMA composites (14-26 MPa) were higher than those of the polyacid cements (7-12 MPa). Both the H2O content and pH may thus be factors controlling the rate and extent of HAp formation in hydrogel composites containing TTCP/DCP mixtures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732787     DOI: 10.2334/josnusd1959.31.372

Source DB:  PubMed          Journal:  J Nihon Univ Sch Dent        ISSN: 0029-0432


  1 in total

1.  The formation of hydroxyapatite-calcium polyacrylate composites.

Authors:  K E Watson; K S Tenhuisen; P W Brown
Journal:  J Mater Sci Mater Med       Date:  1999-04       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.